Alumis Inc. Common Stock (ALMS)
NASDAQ: ALMS
· Real-Time Price · USD
4.60
-0.08 (-1.71%)
At close: Sep 04, 2025, 3:59 PM
-1.71% (1D)
| Bid | 4.6 |
| Market Cap | 478.69M |
| Revenue (ttm) | 23.09M |
| Net Income (ttm) | -227.52M |
| EPS (ttm) | 33.18 |
| PE Ratio (ttm) | 0.14 |
| Forward PE | -1.48 |
| Analyst | Buy |
| Ask | 4.85 |
| Volume | 560,401 |
| Avg. Volume (20D) | 753,403 |
| Open | 4.76 |
| Previous Close | 4.68 |
| Day's Range | 4.32 - 4.76 |
| 52-Week Range | 2.76 - 13.11 |
| Beta | -1.38 |
About ALMS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALMS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ALMS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Alumis Inc. Common Stock is scheduled to release its earnings on
Nov 12, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+18.63%
Alumis shares are trading higher after the company...
Unlock content with
Pro Subscription
5 months ago
+5.82%
Alumis shares are trading higher after the company announced a dermatology collaboration deal with Kaken Pharmaceuticals for ESK-001.
